Boston Scientific
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The nine-figure deal is set to close before the midpoint of 2021.
Judges praised Nutrimedy's patient-dietitian connection platform and BreathResearch's connected lung health analysis device.